These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 25225170)
1. Carvedilol reverses cardiac insufficiency in AKAP5 knockout mice by normalizing the activities of calcineurin and CaMKII. Li X; Matta SM; Sullivan RD; Bahouth SW Cardiovasc Res; 2014 Nov; 104(2):270-9. PubMed ID: 25225170 [TBL] [Abstract][Full Text] [Related]
2. Role of AKAP79/150 protein in β1-adrenergic receptor trafficking and signaling in mammalian cells. Li X; Nooh MM; Bahouth SW J Biol Chem; 2013 Nov; 288(47):33797-33812. PubMed ID: 24121510 [TBL] [Abstract][Full Text] [Related]
3. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937 [TBL] [Abstract][Full Text] [Related]
4. Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Yoo B; Lemaire A; Mangmool S; Wolf MJ; Curcio A; Mao L; Rockman HA Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1377-86. PubMed ID: 19633206 [TBL] [Abstract][Full Text] [Related]
5. Sympathetic stimulation of adult cardiomyocytes requires association of AKAP5 with a subpopulation of L-type calcium channels. Nichols CB; Rossow CF; Navedo MF; Westenbroek RE; Catterall WA; Santana LF; McKnight GS Circ Res; 2010 Sep; 107(6):747-56. PubMed ID: 20671242 [TBL] [Abstract][Full Text] [Related]
7. Interaction between A-kinase anchoring protein 5 and protein kinase A mediates CaMKII/HDAC signaling to inhibit cardiomyocyte hypertrophy after hypoxic reoxygenation. Zhang X; Wang Q; Wang Z; Zhang H; Zhu F; Ma J; Wang W; Chen Z; Wang H Cell Signal; 2023 Mar; 103():110569. PubMed ID: 36565899 [TBL] [Abstract][Full Text] [Related]
8. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve. Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611 [TBL] [Abstract][Full Text] [Related]
9. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway. Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088 [TBL] [Abstract][Full Text] [Related]
10. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway. Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219 [TBL] [Abstract][Full Text] [Related]
11. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B). Wu G; Wang H; Yang J; Yang Y; Liu C; Jing L; Wong TM Eur J Pharmacol; 2008 Oct; 595(1-3):52-7. PubMed ID: 18721804 [TBL] [Abstract][Full Text] [Related]
12. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476 [TBL] [Abstract][Full Text] [Related]
14. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades. Dai H; Jia G; Liu X; Liu Z; Wang H Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447 [TBL] [Abstract][Full Text] [Related]
15. Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility. Wang Q; Wang Y; West TM; Liu Y; Reddy GR; Barbagallo F; Xu B; Shi Q; Deng B; Wei W; Xiang YK Cardiovasc Res; 2021 Aug; 117(10):2237-2251. PubMed ID: 32956449 [TBL] [Abstract][Full Text] [Related]
16. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload. Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050 [TBL] [Abstract][Full Text] [Related]
17. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042 [TBL] [Abstract][Full Text] [Related]
18. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982 [TBL] [Abstract][Full Text] [Related]
19. GRK5 Controls SAP97-Dependent Cardiotoxic β Xu B; Li M; Wang Y; Zhao M; Morotti S; Shi Q; Wang Q; Barbagallo F; Teoh JP; Reddy GR; Bayne EF; Liu Y; Shen A; Puglisi JL; Ge Y; Li J; Grandi E; Nieves-Cintron M; Xiang YK Circ Res; 2020 Aug; 127(6):796-810. PubMed ID: 32507058 [TBL] [Abstract][Full Text] [Related]
20. Calcineurin activity is required for cardiac remodelling in pregnancy. Chung E; Yeung F; Leinwand LA Cardiovasc Res; 2013 Dec; 100(3):402-10. PubMed ID: 23985902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]